119 related articles for article (PubMed ID: 12071417)
21. Self-designing trial combined with classical group sequential monitoring.
Yin G; Shen Y
J Biopharm Stat; 2005; 15(4):667-75. PubMed ID: 16022171
[TBL] [Abstract][Full Text] [Related]
22. A behavioural Bayes approach to the determination of sample size for clinical trials considering efficacy and safety: imbalanced sample size in treatment groups.
Kikuchi T; Gittins J
Stat Methods Med Res; 2011 Aug; 20(4):389-400. PubMed ID: 20223784
[TBL] [Abstract][Full Text] [Related]
23. Hierarchical commensurate and power prior models for adaptive incorporation of historical information in clinical trials.
Hobbs BP; Carlin BP; Mandrekar SJ; Sargent DJ
Biometrics; 2011 Sep; 67(3):1047-56. PubMed ID: 21361892
[TBL] [Abstract][Full Text] [Related]
24. A Bayesian sequential design using alpha spending function to control type I error.
Zhu H; Yu Q
Stat Methods Med Res; 2017 Oct; 26(5):2184-2196. PubMed ID: 26187736
[TBL] [Abstract][Full Text] [Related]
25. Implementing a decision-theoretic design in clinical trials: why and how?
Palmer CR; Shahumyan H
Stat Med; 2007 Nov; 26(27):4939-57. PubMed ID: 17582801
[TBL] [Abstract][Full Text] [Related]
26. Optimal spending functions for asymmetric group sequential designs.
Anderson KM
Biom J; 2007 Jun; 49(3):337-45. PubMed ID: 17623339
[TBL] [Abstract][Full Text] [Related]
27. Approximately optimal designs for phase II clinical studies.
Stallard N
J Biopharm Stat; 1998 Jul; 8(3):469-87. PubMed ID: 9741860
[TBL] [Abstract][Full Text] [Related]
28. Bayesian statistical methods in public health and medicine.
Etzioni RD; Kadane JB
Annu Rev Public Health; 1995; 16():23-41. PubMed ID: 7639872
[TBL] [Abstract][Full Text] [Related]
29. A Bayesian approach for incorporating economic factors in sample size design for clinical trials of individual drugs and portfolios of drugs.
Patel NR; Ankolekar S
Stat Med; 2007 Nov; 26(27):4976-88. PubMed ID: 17579924
[TBL] [Abstract][Full Text] [Related]
30. Sample-size redetermination for repeated measures studies.
Zucker DM; Denne J
Biometrics; 2002 Sep; 58(3):548-59. PubMed ID: 12229989
[TBL] [Abstract][Full Text] [Related]
31. Bayesian designs and the control of frequentist characteristics: a practical solution.
Ventz S; Trippa L
Biometrics; 2015 Mar; 71(1):218-226. PubMed ID: 25196832
[TBL] [Abstract][Full Text] [Related]
32. Sample sizes for phase II clinical trials derived from Bayesian decision theory.
Brunier HC; Whitehead J
Stat Med; 1994 Dec 15-30; 13(23-24):2493-502. PubMed ID: 7701149
[TBL] [Abstract][Full Text] [Related]
33. Evaluating surrogate markers of clinical outcome when measured with error.
Dafni UG; Tsiatis AA
Biometrics; 1998 Dec; 54(4):1445-62. PubMed ID: 9883544
[TBL] [Abstract][Full Text] [Related]
34. Choosing sample sizes to maximize expected health benefits subject to a constraint on total trial costs.
Baker SG; Heidenberger K
Med Decis Making; 1989; 9(1):14-25. PubMed ID: 2492068
[TBL] [Abstract][Full Text] [Related]
35. Optimal sample size determinations from an industry perspective based on the expected value of information.
Willan AR
Clin Trials; 2008; 5(6):587-94. PubMed ID: 19029207
[TBL] [Abstract][Full Text] [Related]
36. Mixtures of prior distributions for predictive Bayesian sample size calculations in clinical trials.
Brutti P; De Santis F; Gubbiotti S
Stat Med; 2009 Jul; 28(17):2185-201. PubMed ID: 19462415
[TBL] [Abstract][Full Text] [Related]
37. A Bayesian sequential design with adaptive randomization for 2-sided hypothesis test.
Yu Q; Zhu L; Zhu H
Pharm Stat; 2017 Nov; 16(6):451-465. PubMed ID: 28980435
[TBL] [Abstract][Full Text] [Related]
38. Adaptive sample size calculations in group sequential trials.
Lehmacher W; Wassmer G
Biometrics; 1999 Dec; 55(4):1286-90. PubMed ID: 11315085
[TBL] [Abstract][Full Text] [Related]
39. Optimal sample size for a series of pilot trials of new agents.
Yao TJ; Begg CB; Livingston PO
Biometrics; 1996 Sep; 52(3):992-1001. PubMed ID: 8805764
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
